These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9208892)

  • 21. A current perspective on the role for molecular studies in soft tissue tumor pathology.
    Dei Tos AP
    Semin Diagn Pathol; 2013 Nov; 30(4):375-81. PubMed ID: 24342291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetics of soft tissue tumours.
    Dal Cin P
    Verh Dtsch Ges Pathol; 1998; 82():47-58. PubMed ID: 10095416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New data on the molecular biology of soft tissue sarcoma].
    Watson S
    Bull Cancer; 2021 Jun; 108(6):654-667. PubMed ID: 33985762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors.
    Graadt van Roggen JF; Bovée JV; van der Woude HJ; Hogendoorn PC
    Curr Opin Rheumatol; 2000 Jan; 12(1):77-83. PubMed ID: 10647959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma.
    Sandberg AA; Bridge JA
    Cancer Genet Cytogenet; 2002 Feb; 133(1):1-23. PubMed ID: 11890984
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular and cytogenetics of soft tissue sarcomas.
    Nilbert M
    Acta Orthop Scand Suppl; 1997 Feb; 273():60-7. PubMed ID: 9057589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular alterations in bladder cancer.
    Cordon-Cardo C
    Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular biology of sarcoma and therapeutic choices].
    Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
    Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytogenetics of bone sarcomas].
    Vagner-Capodano AM; Poitout D
    Chirurgie; 1994-1995; 120(13):188-92. PubMed ID: 8785922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of the c-myc proto-oncogene in soft tissue sarcomas.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    Oncology; 1994; 51(1):13-7. PubMed ID: 8265096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sarcoma related genes in bone soft tissues].
    Hatanaka M
    Nihon Seikeigeka Gakkai Zasshi; 1993 Jan; 67(1):118-25. PubMed ID: 8454921
    [No Abstract]   [Full Text] [Related]  

  • 33. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and molecular abnormalities in tumors of the bone and soft tissues.
    Letson GD; Muro-Cacho CA
    Cancer Control; 2001; 8(3):239-51. PubMed ID: 11378650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetics and the biologic basis of sarcomas.
    Skapek SX; Chui CH
    Curr Opin Oncol; 2000 Jul; 12(4):315-22. PubMed ID: 10888416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
    Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
    Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
    Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
    Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
    Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
    Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.